Table II.
Table presents medians of the percentages of CD62P-positive platelets (%CD62) and the median fluorescence intensity of CD62P expression (med CD62) on resting and thrombin-activated platelets, percentage of platelet-derived microparticles (PDMPs) and soluble P-selectin concentration in blood of the study patients and control subjects
| Study parameters | Median | ||||
|---|---|---|---|---|---|
| Control | NL/NG | NL/HG | HL/NG | HL/HG | |
| %CD62 before thrombin | 2.40 | 1.20* | 1.40* | 1.05* | 1.35 |
| %CD62 after thrombin | 28.45 | 8.00** | 3.80** | 14.35* | 14.40* |
| Med CD62 before thrombin | 6.34 | 5.34* | 4.75* | 4.99* | 4.90** |
| Med CD62 after thrombin | 29.48 | 17.97** | 14.70** | 20.60* | 23.88** |
| PDMPs [%] | 8.30 | 12.80** | 12.55** | 13.20** | 13.25** |
| sP-selectin [ng/ml] | 70.75 | 107.66** | 128.93***# | 124.65***## | 134.11***## |
NL/NG – normolipidemic/normoglycemic group, NL/HG – normolipidemic/hyperglycemic group, HL/NG – hyperlipidemic/normoglycemic group, HL/HG – hyperlipidemic/hyperglycemic group, CS – control subjects; *p < 0.05 vs. control, **p < 0.001 vs. control, ***p < 0.0001 vs. control, #p < 0.01 vs. NL/NG, ##p < 0.001 vs. NL/NG.